Topics

GSK to acquire celiac therapy developer Sitari Pharmaceuticals

06:02 EDT 12 Sep 2019 | SmartBrief

GlaxoSmithKline announced it is set to acquire preclinical-stage biotech firm Sitari Pharmaceuticals, although no financial d -More

Original Article: GSK to acquire celiac therapy developer Sitari Pharmaceuticals

NEXT ARTICLE

More From BioPortfolio on "GSK to acquire celiac therapy developer Sitari Pharmaceuticals"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...